185 related articles for article (PubMed ID: 12855573)
1. STAT1 mediates differentiation of chronic lymphocytic leukemia cells in response to Bryostatin 1.
Battle TE; Frank DA
Blood; 2003 Oct; 102(8):3016-24. PubMed ID: 12855573
[TBL] [Abstract][Full Text] [Related]
2. Bryostatin induces protein kinase C modulation, Mcl-1 up-regulation and phosphorylation of Bcl-2 resulting in cellular differentiation and resistance to drug-induced apoptosis in B-cell chronic lymphocytic leukemia cells.
Thomas A; Pepper C; Hoy T; Bentley P
Leuk Lymphoma; 2004 May; 45(5):997-1008. PubMed ID: 15291360
[TBL] [Abstract][Full Text] [Related]
3. Activation of signal transducer and activator of transcription 1 (STAT1) is not sufficient for the induction of STAT1-dependent genes in endothelial cells. Comparison of interferon-gamma and oncostatin M.
Mahboubi K; Pober JS
J Biol Chem; 2002 Mar; 277(10):8012-21. PubMed ID: 11777927
[TBL] [Abstract][Full Text] [Related]
4. Bryostatin 1 induces differentiation of B-chronic lymphocytic leukemia cells.
Drexler HG; Gignac SM; Jones RA; Scott CS; Pettit GR; Hoffbrand AV
Blood; 1989 Oct; 74(5):1747-57. PubMed ID: 2506950
[TBL] [Abstract][Full Text] [Related]
5. B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues.
Frank DA; Mahajan S; Ritz J
J Clin Invest; 1997 Dec; 100(12):3140-8. PubMed ID: 9399961
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of signal transducer and activator of transcription-1 (STAT1)-dependent gene transcription by lipopolysaccharide and interferon-gamma is regulated by mammalian target of rapamycin.
Kristof AS; Marks-Konczalik J; Billings E; Moss J
J Biol Chem; 2003 Sep; 278(36):33637-44. PubMed ID: 12807916
[TBL] [Abstract][Full Text] [Related]
7. Interferons activate the p42/44 mitogen-activated protein kinase and JAK-STAT (Janus kinase-signal transducer and activator transcription factor) signalling pathways in hepatocytes: differential regulation by acute ethanol via a protein kinase C-dependent mechanism.
Nguyen VA; Chen J; Hong F; Ishac EJ; Gao B
Biochem J; 2000 Jul; 349(Pt 2):427-34. PubMed ID: 10880341
[TBL] [Abstract][Full Text] [Related]
8. In vivo activation of signal transducer and activator of transcription 1 after CD154 gene therapy for chronic lymphocytic leukemia is associated with clinical and immunologic response.
Battle TE; Wierda WG; Rassenti LZ; Zahrieh D; Neuberg D; Kipps TJ; Frank DA
Clin Cancer Res; 2003 Jun; 9(6):2166-72. PubMed ID: 12796382
[TBL] [Abstract][Full Text] [Related]
9. Effect of serum and antioxidants on the immunogenicity of protein kinase C-activated chronic lymphocytic leukemia cells.
Hammond C; Shi Y; Mena J; Tomic J; Cervi D; He L; Millar AE; Debenedette M; Schuh AC; Baryza JL; Wender PA; Radvanyi L; Spaner DE
J Immunother; 2005; 28(1):28-39. PubMed ID: 15614042
[TBL] [Abstract][Full Text] [Related]
10. VEGF receptors on chronic lymphocytic leukemia (CLL) B cells interact with STAT 1 and 3: implication for apoptosis resistance.
Lee YK; Shanafelt TD; Bone ND; Strege AK; Jelinek DF; Kay NE
Leukemia; 2005 Apr; 19(4):513-23. PubMed ID: 15703780
[TBL] [Abstract][Full Text] [Related]
11. The cytotoxicity of anti-CD22 immunotoxin is enhanced by bryostatin 1 in B-cell lymphomas through CD22 upregulation and PKC-βII depletion.
Biberacher V; Decker T; Oelsner M; Wagner M; Bogner C; Schmidt B; Kreitman RJ; Peschel C; Pastan I; Meyer Zum Büschenfelde C; Ringshausen I
Haematologica; 2012 May; 97(5):771-9. PubMed ID: 22180432
[TBL] [Abstract][Full Text] [Related]
12. STAT1 is required for IFN-gamma-mediated gut-enriched Krüppel-like factor expression.
Chen ZY; Shie JL; Tseng CC
Exp Cell Res; 2002 Nov; 281(1):19-27. PubMed ID: 12441126
[TBL] [Abstract][Full Text] [Related]
13. p38 MAPK enhances STAT1-dependent transcription independently of Ser-727 phosphorylation.
Ramsauer K; Sadzak I; Porras A; Pilz A; Nebreda AR; Decker T; Kovarik P
Proc Natl Acad Sci U S A; 2002 Oct; 99(20):12859-64. PubMed ID: 12232043
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of IFN-gamma-mediated inducible nitric oxide synthase induction by the peroxisome proliferator-activated receptor gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, involves inhibition of the upstream Janus kinase/STAT1 signaling pathway.
Chen CW; Chang YH; Tsi CJ; Lin WW
J Immunol; 2003 Jul; 171(2):979-88. PubMed ID: 12847270
[TBL] [Abstract][Full Text] [Related]
15. Differential role of Janus family kinases (JAKs) in interferon-gamma-induced lung epithelial ICAM-1 expression: involving protein interactions between JAKs, phospholipase Cgamma, c-Src, and STAT1.
Chang YJ; Holtzman MJ; Chen CC
Mol Pharmacol; 2004 Mar; 65(3):589-98. PubMed ID: 14978237
[TBL] [Abstract][Full Text] [Related]
16. Role of the STAT1 pathway in apoptosis induced by fludarabine and JAK kinase inhibitors in B-cell chronic lymphocytic leukemia.
Martinez-Lostao L; Briones J; Forné I; Martinez-Gallo M; Ferrer B; Sierra J; Rodriguez-Sanchez JL; Juarez C
Leuk Lymphoma; 2005 Mar; 46(3):435-42. PubMed ID: 15621835
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of 2-chlorodeoxyadenosine activity by bryostatin 1 in the resistant chronic lymphocytic leukemia cell line (WSU-CLL): association with increased ratios of dCK/5'-NT and Bax/Bcl-2.
Mohammad RM; Beck FW; Katato K; Hamdy N; Wall N; Al-Katib A
Biol Chem; 1998 Oct; 379(10):1253-61. PubMed ID: 9820586
[TBL] [Abstract][Full Text] [Related]
18. Protein tyrosine kinase Pyk2 mediates the Jak-dependent activation of MAPK and Stat1 in IFN-gamma, but not IFN-alpha, signaling.
Takaoka A; Tanaka N; Mitani Y; Miyazaki T; Fujii H; Sato M; Kovarik P; Decker T; Schlessinger J; Taniguchi T
EMBO J; 1999 May; 18(9):2480-8. PubMed ID: 10228162
[TBL] [Abstract][Full Text] [Related]
19. SHP-2 is a dual-specificity phosphatase involved in Stat1 dephosphorylation at both tyrosine and serine residues in nuclei.
Wu TR; Hong YK; Wang XD; Ling MY; Dragoi AM; Chung AS; Campbell AG; Han ZY; Feng GS; Chin YE
J Biol Chem; 2002 Dec; 277(49):47572-80. PubMed ID: 12270932
[TBL] [Abstract][Full Text] [Related]
20. Characterization of interleukin-10 receptor expression on B-cell chronic lymphocytic leukemia cells.
Jurlander J; Lai CF; Tan J; Chou CC; Geisler CH; Schriber J; Blumenson LE; Narula SK; Baumann H; Caligiuri MA
Blood; 1997 Jun; 89(11):4146-52. PubMed ID: 9166857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
